Dr. Michael Burnstine's Curriculum Vitae

Michael A. Burnstine, M.D.

Michael A. Burnstine, M.D.

Clinical Professor of Ophthalmology

Technical Writings

Curriculum Vitae
Biography

Michael Alan Burnstine, M.D., F.A.C.S.
Personal Information
Name in FullMichael Alan Burnstine, M.D., F.A.C.S.
Business AddressEyesthetica 1513 South Grand Avenue Suite 200, Los Angeles, CA 90015
Business Phone(213) 234-1000
Business FAX(213) 234-1001
Date of BirthJuly 18, 1965
Place of BirthDetroit, MI
CitizenshipU.S.A.
Marital StatusMarried
Spouse’s NameDiana Sue Lorden
ChildrenAdam Bailey, d.o.b. June 26, 2002 Zachary Thomas, d.o.b. January 16, 2006
Education
High SchoolAndover High School, Bloomfield Hills, MI, 1983
UndergraduateUniversity of Michigan, Ann Arbor 1983-86, B.S. with highest distinction, high honors in Biology
GraduateCambridge University, England, 1986-87, Immunology
Professional InternshipHarvard Medical School, 1987-92, M.D.
Internal Medicine, Massachusetts General Hospital, Boston, 1992-93
Residency FellowshipOphthalmology, University of Michigan, 1993-96
Oculoplastics, Allen M. Putterman, M.D., UIC, Chicago, 1996-97
Honors and AwardsBranstrom Freshman Prize, 1983 Class Honors, 1983-86 James B. Angell Scholar, 1984-86 Phi Beta Kappa, 1986 Golden Key National Honor Society, 1986 Honors College Award for Research, 1986 Quickert Award for ASOPRS thesis, 1997 Merrill Reeh Pathology Award, 2000 Honor Award, AAO, 2004
LicensureMassachusetts: Educational: 92-7396-93, 6/25/92 Michigan: Educational: 4301061161; 7/1/93 Illinois: 036-092739; exp. 7/31/99 California: G083967; exp. 7/31/07 DEA: BB4921448; exp. 7/31/08
Board CertificationNational Board of Medical Examiners, 1993 American Board of Ophthalmology, 1998, 2008
Professional Background
Academic Appointments
Clinical Fellow in Internal Medicine, Harvard Medical School, 1992-93
Resident in Ophthalmology, University of Michigan, 1993-96
Chief Resident in Ophthalmology, University of Michigan, 1995-96
Fellow in Oculoplastics, University of Illinois – Chicago, 1996-97
Assistant Professor of Ophthalmology, University of Southern California, 1997-2002
Associate Clinical Professor of Ophthalmology, USC, 2002-2014
Clinical Professor of Ophthalmology, USC, 2014-present.
Specific Teaching ResponsibilitiesDirector, Ophthalmology Medical Student Education, USC Medical School, 1997-2000
Medical student lecturer, 1997 – 2002Education Policy Committee Clinical Curriculum Committee
Year II lecture on Visual loss (1 hour): 1 lecture/year.
Year III/IV Surgical Subspecialties, Ocular Anatomy lecture (1hour);13/year
Mentor Year III/IV medical students
• Ken Krantz
• Michelle Britt
• Armen Adjemian
• Paul Nazemi
Resident education, 1997 – 2002Instruct residents in clinic and operating room at L.A. County 3 days per month.
Fellow EducationAssociate Preceptor, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) – approved Oculoplastic Fellowship at USC, 2001 –
• Nicolas Uzcategui, M.D., 2001-2003
• Harry Marshak, M.D., 2003-2005
• Alan W. McInnes, M.D., 2007-2009
• Srinivas Iyengar, MD, 2009-2011
• David B. Samimi, MD, 2011-2013
• Priya Sahu, MD, 2013-2015
Specific Administrative Responsibilities Director, Oculoplastic and Reconstructive Surgery, USC Medical School, 1997- 2002
Member, Ophthalmology Resident Training Committee, 1997-2002
Member, Executive Committee, Doheny Eye Medical Group, Inc., 1997- 2002
Member, Quality Outcome Subcom, USC Care Medical Group, Inc., 1998-2000
Member, Taskforce Resident Education, 1998
Interviewer, Admissions, Keck School of Medicine at USC, 1999 – 2002
Medical Director, Doheny Eye Medical Group Inc., 2000 – 2002
Partner, Eyesthetica, Inc, 2004-
Military ServiceNone
Other Employment or ActivityMember, Craniofacial Team, Children’s Hospital – Los Angeles, 1997- 2002
Member, Education Committee, American Society of Ophthalmic Plastic and Reconstructive Surgeons (ASOPRS), 2002-
Society Memberships
Local
Los Angeles County Medical Association, 1997-1999
California Medical Association, 1997-1999
Los Angeles Ophthalmology Society, 1997-
California Academy of Ophthalmology, 1997-
National
American Medical Association, 1987- 2000
Massachusetts Medical Society (MMS), 1987-
Physicians for Human Rights, 1992-
American Academy of Ophthalmology, Fellow, 1998-
American Society of Ophthalmic Plastic and Reconstructive Surgery, Fellow, 1998-
Pan-American Association of Ophthalmology, 2000- American College of Surgeons, Fellow, 2001-
Consultantships
Hospital Appointments
Columbia-Michael Reese Hospital, Chicago, Illinois, 1996-97
Illinois Eye and Ear Infirmary, Chicago, Illinois, 1996-97
Illinois Masonic Hospital, Chicago, Illinois, 1996-97
Veterans Administration Outpatient Facility, Los Angeles, California, 1997-98
California Hospital Medical Center, Los Angeles, California, 1998-2000; 2002-
City of Hope National Medical Center, Duarte, California, 1998-2000
Methodist Hospital, Arcadia, California, 1997- 2001
Los Angeles County Hospital, Los Angeles, California, 1997-
University Hospital, University of Southern California, Los Angeles, California, 1997-
Children’s Hospital of Los Angeles, Los Angeles, California, 1997- 2005
Outpatient Surgery Center, Arcadia, California, 1997-
El Mirador Surgery Center, Palm Springs, California, 1997-2011
Good Samaritan Hospital, Los Angeles, California, 2002-2015
Huntington Memorial Hospital, Pasadena, California, 2002-
Huntington Outpatient Surgery Center, Pasadena, California, 2002-
Surgery Center of Santa Monica, Santa Monica, California, 2002-
Saint Vincent’s Hospital, Los Angeles, CA, 2006-2011
Scientific Referee (Ad Hoc)
American Journal of Ophthalmology, 1999-
Archives of Ophthalmology, 1997-
British Journal of Ophthalmology, 1997-
Indian Journal of Ophthalmology Ophthalmology, 1997-
Ophthalmic Plastic and Reconstructive Surgery, 1999-
Slack Publishing Co., Book Review, 2000 –
Research Activities
BIBLIOGRAPHY Peer Reviewed Papers
1Burnstine MA, Levin LA, Louis DA, Hedley-Whyte WJ, Kupsky EJ, Doepner DD, Albert DM. Nucleolar organizer regions in optic gliomas, Brain, 1993; 116:1465-76.
2Burnstine MA, Headington JT, Reifler DM, Oestricher JH, Elner VM. Periocular granuloma annulare, nodular type: Occurrence in late middle age, Archives of Ophthalmology, 1994; 112:1590-3.
3Elner VM, Burnstine MA, Goodman ML, Dortzbach RL. Inverted papillomas that Invade the orbit, Archives of Ophthalmology, 1995; 113:1178-83.
4Burnstine MA, Frueh BR, Elner VM. Angiosarcoma metastatic to orbit, Archives of Ophthalmology, 1996; 114:93-96.
5Burnstine MA, Elner VM. Golf-related ocular injuries, American Journal of Ophthalmology, 1996; 121:437-38.
6Esmaeli B, Burnstine MA, Martonyi CL, Sugar A, Johnson V, Brewer GJ. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson’s disease, Cornea, 1996; 15:582-86.
7Strome SW, Hill JS, Burnstine MA, Beck J, Esclamado RM. Anterior ischemic optic neuropathy following neck dissection, Head and Neck, 1997; 19:148-52.
8Rodman RC, Burnstine MA, Esmaeli B, Sugar A, Martonyi CL, Johnson V, Brewer GJ. Wilson’s disease: presymptomatic patients and Kayser-Fleischer rings, Ophthalmic Genetics, 1997; 18:79-85.
9Burnstine MA, Elner SG, Elner VM. Interleukin-6 gene expression and inhibition by cytokine-stimulated orbital fibroblasts, ASOPRS thesis, November 1997.
10Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in situ hybridization analyses, Experimental Eye Research, 1997; 65:781-89.
11Elner VM, Burnstine MA, Kunkel SL, Strieter RM, Elner SG. Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts, Ophthalmic Plastic and Reconstructive Surgery, 1998; 14:119-125.
12Burnstine MA, Elner SG, Elner VM. Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A, British Journal of Ophthalmology, 1998; 82:318-322.
13Putterman AM, Autogenous fascia lata leg grafts for exposed scleral buckles, Retina, 1998; 18:283-285.
14Burnstine MA, Morton AD, Font RL, Boniuk M, Flint A, Meyer KA, Elner VM. Lacrimal gland hemangiopericytoma, Orbit, 1998; 17:189-94.
15Britt, MT, Burnstine MA, Iopidine allergy causing lower eyelid ectropion progressing to cicatricial entropion, British Journal of Ophthalmology, 1999; 83:992-93.
16Burnstine MA, Elner SG, Streiter RM, Kunkel SL, Elner VM. Interleukin-6 gene expression and inhibition by cytokine-stimulated orbital fibroblasts, Ophthalmic Plastic and Reconstructive Surgery, 1999; 15:306-311.
17Burnstine MA, Putterman AM. Upper blepharoplasty: a novel approach to progressive myopathic blepharoptosis, Ophthalmology, 1999; 106:2098-2100.
18Burnstine MA, Sugar J, Putterman AM. Cicatricial entropion caused by asymptomatic allergic conjunctivitis, Orbit, 1999; 16: 211-216.
19Burnstine MA, Discussion of primary implant placement with evisceration in patients with endophthalmitis. Ophthalmology, 2000; 107; 1664-65.
20Adjemian A, Burnstine MA, Lacrimal canalicular diverticulum, a cause of epiphora and discharge, Ophthalmic Plastic Reconstructive Surgery, 2000; 16; 471-2.
21Read RW, Burnstine MA, Rowland JM, Zamir E, Rao NA. Rhabdomyomatous mesenchymal hamartoma of the eyelid: report of a case and literature review. Ophthalmology, 2001; 108: 798-804.
22Saks ND, Burnstine MA, Putterman AM. Glabellar rhytids in thyroid-associated orbitopathy, Ophthalmic Plastic and Reconstructive Surgery, 2001; 17: 91-95.
23Nazemi PP, Chong LP, Varma R, Burnstine MA, Migration of silicone oil into the subconjunctival space and orbit through an Ahmed glaucoma valve, American Journal of Ophthalmology, 2001; 132: 929-931.
24Burnstine MA, Indications and timing for repair of isolated orbital floor fractures: an evidence-based analysis, Ophthalmology, 2002; 109: 1207-1213.
25Zamir E, Smith RE, See RF, Yiu SC, Burnstine MA, Rao NA. Squamous cell carcinoma of the limbus extending into the anterior segment. Archives of Ophthalmology, 2002; 120: 1106-1107.
26Agarwal MR, Esmaeli B, Burnstine MA, Squamous metaplasia of the canaliculi secondary to 5-luorouracil: a clinicopathologic case report, Ophthalmology, 2002; 109: 2359-2361.
27Esmaeli B, Burnstine MA, Ahmadi A, Prieto VG. Docetal- induced histologic changes in the lacrimal sac and nasal mucosa, Ophth Plast Reconstr. Surg 2003; 19: 305-308.
28Burnstine MA, Clinical recommendations for repair of orbital facial fractures. Curr Opin Ophthalmol 2003; 14: 236-240.
29Burnstine MA, New lacrimal cannula for probing and irrigation in the tearing patient. Archives of Ophthalmology, 2007; 125: 419.
30Zoumalan C, Rao N, See R, Burnstine M, Shah S, McCulley T.., Periorbital xanthogranuloma after Blepharoplasty. British Journal of Ophthalmology, 2007; 91: 1088-1089.
31Dresner SC, Uzcategui N, Burnstine MA, Orbitotemporal Neurofibromitis: classification and treatment, Orbit, 2007; 26:223-228.
32Parikh JG, Burnstine MA, Kase S, Rao N. Salivary duct carcinoma metastatic to eyelid and orbit: a case report. Graefes Arch Clin Exp Ophthalmol 2008, 246: 1185-8.
33McInnes AW and Burnstine MA, The white-eyed medial wall blow-out fracture. OPRS, 2010; 26: 44-46.
34Iyengar S and Burnstine MA, Treatment of symptomatic facial nerve paralysis with lower eyelid fascia lata suspension. Plastic and Reconstructive Surgery, 2012, 129:569e-571e.
35Samimi DB, Chiu GB, Burnstine MA, PROSE Scleral Lens: A Novel Aid for Staged Eyelid Reconstruction. Ophthal Plast Reconstr Surg., 2013
36Samimi DB, Perry AC, Burnstine MA, Dresner SC. On-Q Pump for Pain Control after Orbital Implant Surgery. Ophthal Plast Reconstr Surg, 2014.
37Burnstine MA, Sahu PD. Orbital hemorrghage. AAO/ASOPRS OPS Knowledge Center, 2014.
38Burnstine MA, Frontalis suspension and other alternative techniques for ptosis repair. AAO/ASOPRS OPS Knowledge Center, 2014.
39Strome SW, Hill JS, Burnstine MA, Sahu SD. Lacrimal outflow system trauma. AAO/ASOPRS OPS Knowledge Center, 2014.
Articles In Press
Articles Submitted
Articles In Preparation
1Krantz KB, Nguyen R, Quiros P, Burnstine MA, Sinha UK, Rao NA. Sebaceous cell carcinoma: natural history of a neglected tumor.
2Burnstine MA, Putterman AM, Valvassori GE, Mafee MF. Extraocular muscle fatty infiltration: a new finding in thyroid-associated orbitopathy.
Non-Peer Review
1Charters L, Kaplan L, Burnstine MA, Erbium, C02 lasers play big role in oculoplastics field. Ophthalmology Times, 1998; 23:24:12,26.
2Charters L, Burnstine MA, Upper blepharoplasty an alternative for ptosis in CPEO. Ophthalmology Times, 1999; 24:1;36.
3Burnstine MA, Putterman AM. Bobbypin ptosis procedure not “new”. Ophthalmology Times, 1999; 24:8;4.
4Ngoe, Enette. Filler up. The lower cost of in-office procedures like dermal fillers increases the demand for them during the economic slump. Eyeworld 2009; 14: 31-5.
Major areas of research interest
1.Disorders of eyelids, lacrimal system, and orbit
2.Facial rejuvenation
Research in Progress
Research Grants
None
Book Reviews
1Burnstine MA Cosmetic Oculoplastic Surgery: Eyelid, forehead and facial techniques By Allen M. Putterman, Archives of Ophthalmology, 1999; 117:1100-01.
2Burnstine MA Oculoplastic Surgery, the Requisites by Jeffrey A. Nerad. Archives of Ophthalmology, 2002; 120: 1603.
Letters to the Editors
1Putterman AM, Burnstine MA Reversal of iatrogenic punctal and cannalicular occlusion, Ophthalmology, 1997; 104:901-02.
2Burnstine MA Minimal endoscopic approach, Arch Otolaryngol Head Neck Surgery, 1998; 124:711.
3Burnstine MA Putterman AM. Myogenic ptosis, Ophthalmology, 2004; 111: 411.
4Uzcategui N, Burnstine MA Dresner SC, Comparison of Retrobulbar Analgesics for Evisceration, Ophthalmic Plastic and Reconstructive Surgery, 2003, 19: 411.
5Iyengar SS, Petrus L, Burnstine MA Re: Radiologic Analysis of Extraocular Muscle Volumetric Changes in Thyroid-Related Orbitopathy Following Orbital Decompression, Ophthalmic Plastic and Reconstructive Surgery, 2011, 27:144-5.
Chapters
1Putterman AM, Burnstine MA Lower blepharoplasty: transconjunctival approach. In: Facial Plastic and Reconstructive Surgery. Ed. Toriumi D. Lippincott-Raven, Philadelphia, PA, 2002.
2Burnstine MA Putterman AM. Midface Lift. In: Facial Plastic and Reconstructive Surgery. Ed. Toriumi D. Lippincott-Raven, Philadelphia, PA, 2002.
3Burnstine MA The Ocular Adnexa – Eyelids: Ectropion. In: Corneal and Extrenal Diseases. Ed. O’Brien T, McDonnel PJ, Thieme Medical Publishers, Inc., New York, New York, (submitted).
4Burnstine MA Putterman AM. Upper blepharoplasty: a novel approach to progressive myopathic blepharoptosis. Advances in Plastic Surgery, (in press)
5Burnstine MA Ectropion. In Probst LE ed. Ophthalmology: Clinical and Surgical Principles, Slack, Inc, 2008
6Burnstine MA Entropion. In Probst LE ed. Ophthalmology: Clinical and Surgical Principles, Slack, Inc, 2008.
7Samimi DB, Burnstine MA Internal Vertical Mattress Eyelid Reconstruction. Pears and Pitfalls of Cosmetic Oculoplastic Surgery. Springer, New York, NY. In press 2013.
Posters
1Burnstine MA Levine LA, Louis DA, Hedley-Whyte ET, Kupsky WJ, Doepner DD, Albert DM. Nucleolar organizer regions in optic gliomas, Association for Research in Vision and Ophthalmology (ARVO), Sarasota, Florida, May 1992.
2Esmaeli B, Burnstine MA Brewer GJ, Martonyi CL. Disappearance of Kayser Fleischer rings in response to anti-copper therapy in patients with Wilson’s Disease, American Academy of Ophthalmology, San Francisco, California, November 1994.
3Rodman, RC, Burnstine MA Esmaeli B, Sugar A, Martonyi CL, Johnson V, Brewer GJ. Wilson’s disease: presymptomatic patients and Kayser-Fleischer rings, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, April 1996.
4Dresner SC, Uzcategui N, Burnstine MA Putterman AM. Orbitotemporal neurofibromatosis: classification and treatment. American Society ofOphthalmic Plastic and Reconstructive Surgery (ASOPRS), Orlando, Florida, October,2002.
5Agrawal R, Humayun MS, Fujii GY, Freda R, Greenberg R, Little J, Mech B, Mahadevappa M, Weiland JD, Yanai D, Maceri D, Burnstine MA Chang EL, DeJuan, E. Surgical outcomes and stimulation test results of intraocular retinal prosthesis implantation in candidate patients, American Academy of Ophthalmology (AAO), New Orleans, Louisiana, October 24, 2004.
6Burnstine MA A new lacrimal cannula to assess the tear drainage system, American Academy of Ophthalmology, Las Vegas, Nevada, November11-Novemebr 16, 2006.
7Dresner SD, Marshak H, Burnstine MA Perry AC. Evaluation of a continuous infusion, pain management system for post-operative pain control after enucleation or evisceration, American Academy of Ophthalmology, Las Vegas, Nevada, November 11-15, 2006.
8Burnstine MA Dresner SC, The functional margin-to-reflex distance (MRDf): a new measurement for evaluating upper eyelid malposition for dermatochalasis, American Academy of Ophthalmology, Las Vegas, Nevada, November 11-15, 2006.
9Dresner SD, Marshak H, Burnstine MA Perry AC. Evaluation of a continuous infusion, pain management system for post-operative pain control after enucleation, evisceration, or secondary orbital implantation, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Las Vegas, Nevada, November 15-16, 2006.
10Iyengar SS, Burnstine MA Dresner SC. Treatment of symptomatic facial palsy with lid suspension as a primary procedure. Poster 2393/D941, Association of Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Fl, May 2010.
Presentations
Local
1Burnstine MA Inverted papillomas that invade the orbit, Scientific Program, University of Michigan, June 1994.
2Burnstine MA Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson’s disease, Scientific Program, University of Michigan, June 1995.
3Burnstine MA Interleukin-8, monocyte chemotatic protein-1, and orbital fibroblasts: a possible role in orbital inflammation, Scientific Program, University of Michigan, June 1996.
4Burnstine MA Autogenous fascia lata leg grafts for exposed scleral buckles, Scientific Program, University of Illinois at Chicago – Eye and Ear Infirmary, June 1997.
5Burnstine MA CT and MRI of the eye and orbit, CME, Doheny Eye Institute, University of Southern California, November 8, 1997.
6Burnstine MA Update in orbit: exam and orbital trauma, CME, Doheny Eye Institute, University of Southern California, March 14, 1998.
7Burnstine MA Upper blepharoplasty: a novel approach to progressive external ophthalmoplegia, CME, Doheny Days, University of Southern California, June 13, 1998.
8Burnstine MA Eyelid reconstruction, ENT Grand Rounds, Los Angeles County and USC Medical Center, Los Angeles, California, August 8, 1998.
9Burnstine MA The socket, CME, Doheny Eye Institute, University of Southern California, March 13, 1999.
10Burnstine MA Glabellar rhytids in thyroid-associated orbitopathy, CME, Doheny Days, University of Southern California, June 11, 1999.
11Burnstine MA Indications and timing for repair of isolated orbital floor fractures: an evidence-based analysis, Doheny Days, University of Southern California, June 10, 2000.
12Burnstine MA Ocular Aesthetics, CME, Doheny Eye Institute, University of Southern California (Course Director and lecturer on “A Rational Approach to the Aging Face”), October 14, 2000.
13Burnstine MA Transconjunctival lower blepharoplasty. 70th Annual Midwinter Ophthalmology Conference. Research Study Club of Los Angeles, Los Angeles, CA, January 27, 2001.
14Burnstine MA Temporoorbital Neurofibromatosis: diagnosis and management; Doheny Days, University of Southern California, June 15, 2001.
15Burnstine MA “The Aging Face”. Chapman Medical Center, Orange, CA, July 12, 2001.
16Burnstine MA Ectropion: diagnosis and management. California Academy of Ophthalmology, Santa Monica, CA, September 15, 2001.
17Burnstine MA The Aging Face. San Diego County Eye Society, San Diego, CA, October 15, 2001.
18Burnstine MA Autogenous fascia lata leg grafts for exposed scleral buckles, Doheny Days, University of Southern California, June 8, 2002.
19Burnstine MA Blepharoplasty of the lower lid with finesse, Ocular Aesthetics CME Course, Doheny Eye Institute, University of Southern California, November 9, 2002.
20Burnstine MA Binder WJ, Blumfeld A, Burke GS, Desner SC., Botox and its Uses, 72nd Mid-Winter Clinical Conference for Otolaryngology and Ophthalmology, The Research Study Club of Los Angeles, January 16, 2004
21Burnstine MA Evaluation and Management of Ptosis, 72nd Mid-Winter Clinical Conference for Otolaryngology and Ophthalmology, The Research Study Club of Los Angeles, January 16, 2004
22Burnstine MA Thyroid Eye Disease, 73rd Mid- Winter Clinical Conference, The Research Study Club of Los Angeles, January 22, 2005.
23Burnstine MA Management of Orbital Blow-out Fractures, Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeles, Ca, February 11, 2006.
24Burnstine MA Update on Graves’ Disease, , Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeles, Ca, February 11, 2006.
25Burnstine MA Development of a new lacrimal cannula for probing and irrigation in the tearing patient, CME, Doheny Days, Doheny Eye Institute, University of Southern California, Los Angeles, CA June 16, 2006.
26Burnstine MA Top Five Reasons to Request an Oculofacial Consultation. Eye on 2006, Huntington Memorial Hospital, Pasadena, California, August 19, 2006.
27Burnstine MA Evaluation and Management of the Tearing Patient, San Gabriel Optometric Association, Pasadena, California, September 13, 2006.
28Burnstine MA Ophthalmic management of facial nerve paralysis. Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeles, CA, February 24, 2007.
29Burnstine MA Upper blepharoplasty: a novel approach to improve progressive myopathic ptosis, California Hospital Medical Center, Los Angeles, CA, February 24, 2007.
30Burnstine MA Is lid loading necessary in patients with facial nerve paralysis? CME, Doheny Days, Doheny Eye Institute, University of Southern California, Los Angeles, CA, June 16, 2007.
31Burnstine MA Classification of ptosis, 3rd Annual Update on Oculofacial Plastic Surgery. California Hospital Medical Center, Los Angeles, CA, February 9, 2008
32Burnstine MA Small incision levator surgery for congenital ptosis. 3rd Annual Update on Oculofacial Plastic Surgery. California Hospital Medical Center, Los Angeles, CA, February 9, 2008.
33Burnstine MA Small incision levator surgery for congenital ptosis. 39th Annual Doheny Days Conference, Los Angeles, CA, June 13, 2008.
34Burnstine MA Management of Blow Out Fractures, an Evidence-Based Approach, Update on Oculofacial Plastic Surgery. California Hospital Medical Center, Los Angeles, California, February 7, 2009.
35Burnstine MA Decompression Surgery for Thyroid Eye Disease, Update on Oculofacial Plastic Surgery. California Hospital Medical Center, Los Angeles, California, February 7, 2009.
36Burnstine MA Correction of Upper Eyelid Retraction, Update on Oculofacial Plastic Surgery. California Hospital Medical Center, Los Angeles, California, February 7, 2009.
37Burnstine MA Electronic Health Record Implementation: Lessons Learned. 40th Annual Doheny Days Conference, University of Southern California, Los Angeles, CA , June 12/13, 2009.
38Burnstine MA Lacrimal Trauma and Canalicular Repair, 5th Annual Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeles, CA, February 13, 2010.
39Burnstine MA Ectropion repair: variations and subtleties of repair. 6th Annual Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeles, CA, February 12, 2011.
40Burnstine MA Entropion Repair, Inside and Outside. 6th Annual Update on Oculofacial plastic Surgery, California Hospital Medical Center, Los Angeles, CA, February 12, 2011.
41Burnstine MA Treatment of symptomatic facial nerve paralysis with lower eyelid fascia lata suspension. Doheny Days, Los Angeles, CA, June 10, 2011.
42Burnstine MA Treatment of symptomatic facial nerve paralysis with lower eyelid fascia lata suspension, Grand Rounds, House Ear Institute, Los Angeles, CA, August 12, 2011.
43Burnstine MA Cosmetic Surgery in Patients with Thyroid-Related Immune Orbitopathy (TRIO), 7th Annual Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeless, CA, March 3, 2012.
44Burnstine MA Graded Transantral Orbital Decompression for Thyroid-Related Immune Orbitopathy, 43rd Doheny Days Conference, Los Angeles, CA, June 15, 2012.
45Burnstine MA The Aging Face: A Paradigm Shift to Fillers. 8th Annual Update on Oculofacial Plastic Surgery, California Hospital Medical Center, Los Angeles, CA, March 2, 2013.
46Burnstine MA Chou G, and Samimi D. PROSE Therapy: A novel aid for staged eyelid reconstruction, Doheny Days Conference, Los Angeles, CA Jun15, 2013.
47Burnstine MA Cutaneous Laser Use in an Oculofacial Practice. 9th Annual Oculofacial plastic Surgery Update, California Hospital Medical Center, Los Angeles, CA March 1, 2014.
48Burnstine MA Cosmetic Surgery in Patients with Thyroid Eye Disease, An Update on Thyroid Eye Disease, Keck School of Medicine of USC, May 10, 2014.
National/International
1Elner VM, Burnstine MA Goodman ML, Dortzbach RL. Inverted papillomas that Invade the orbit, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), San Francisco, California, October 1994.
2Burnstine MA Orbital fibroblast interleukin-6 gene expression and immunomodulation, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), San Francisco, California, October 25, 1997.
3Saks N, Burnstine MA Putterman AM. A new clinical finding in thyroid-associated orbitopathy: glabeller furrows, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), New Orleans, Louisiana, November 7, 1998.
4Burnstine MA Putterman AM. Upper blepharoplasty: a novel approach to progressive external ophthalmoplegia, American Academy of Ophthalmology (AAO), New Orleans, Louisiana, November 10, 1998.
5Burnstine MA Cases of lower eyelid avulsion and assymetric margin fold distances after upper blepharoplasty, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Spring Meeting, Phoenix, Arizona, May 19, 1999.
6Burnstine MA Liu N, Smith RE, Chuck R Amniotic membrane transplantation: the Doheny Eye Institute experience. European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Istanbul, Turkey, September 16, 1999.
7Burnstine MA Olson, JJ. Cicatricial entropion treated by amniotic membrane spacer graft placement. American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Orlando, Florida, October 23, 1999.
8Burnstine MA Putterman AM. Upper blepharoplasty: a novel approach to improving progressive myopathic blepharoptosis. Pan American Association of Ophthalmology/American Academy of Ophthalmology, Orlando, Florida, October 24, 1999.
9Burnstine MA Discussion of paper by Steven Dresner: Primary implant placement with evisceration in patients with endophthalmitis. American Academy of Ophthalmology, Orlando, Florida, October 26, 1999.
10Burnstine MA Eyelid Reconstruction after inadvertant levator excision during blepharoplasty. American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Spring Meeting, Hot Springs, VA, June 20, 2000.
11Burnstine MA Indications and timing for repair of isolated orbital floor fractures: an evidence-based analysis, European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Paris, France, September 15, 2000.
12Burnstine MA Indications and timing for repair of isolated orbital floor fractures: an evidence – based analysis. American Academy of Ophthalmology (AAO), Dallas, TX, October 25, 2000.
13Dresner SC, Uzcategui N, Burnstine MA MRDf and MRDp: two new measurements for evaluating upper eyelid malpositions, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Orlando, FL, October 19, 2002.
14Agrawal R, Humayun MS, Fujii GY, Weiland, JD, Greenberg R, Little J, Mech B, Maceri D, Burnstine MA Chang EL, DeJuan, E. Steps in surgical implantation of an intraocular retinal prosthetic (IRP) artificial vision device in candidate patients, American Academy of Ophthalmology (AAO), New Orleans, Louisiana, October, 2004. (Best of Show Video Presentation).
15Burnstine MA Small Incision repair of congenital ptosis, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Fall Meeting, New Orleans, Louisiana, November 10, 2007
16Burnstine MA Electronic Health Record Implementation: Lessons Learned. 2009 Annual Spring Symposium, ASOPRS, Ritz-Carlton, Laguna Niguel, Dana Point, California, July 16, 2009.
17Burnstine MA Ophthalmic Plastic and Reconstructive Surgery Coding Panel. 2009 Annual Spring Symposium, ASOPRS, Ritz-Carlton, Laguna Niguel, Dana Point, California, July 16, 2009.
18Iynegar S, Burnstine MA and Dresner SD. Inferior Oblique Fixation in Enucleation with the Smooth Surface Tunnel Porous Polyethylene Implant. 41st Annual American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Chicago, IL, October 14, 2010.
19Dresner SC, Burnstine MA Brown M, Ng J, McCracken M. Roundtable on EMR Use. Spring Meeting of Americal Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Spring Meeting, Ritz Carlton Dove Mountain, Tucson, AZ, May 19. 2012.
20Samimi D, Burnstine MA and Chou G. PROSE Therapy: A novel aid for staged eyelid reconstruction, American Society of Ophthalmic Plastic and Reconstructive Surgery, Chicago, IL 2012.
21Samimi D, Burnstine MA Dresner SC. On Q Pain Management System for Orbital Surgery. American Society of Ocularists Meeting. Chicago, IL. November 11, 2012.
American Academy of Ophthalmology Courses
1Tanenbaum M, Holds JB, Burnstine MA Mazzoli RA, Maus M. Ask the Experts. American Academy of Ophthalmology, San Francisco, California, October 26-29, 1997.
2Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Reino AJ, Farrior E, Burnstine MA Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology (AAO), Orlando, Florida, October 27, 1999.
2Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Reino AJ, Farrior E, Burnstine MA Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology (AAO), Orlando, Florida, October 27, 1999.
3Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Reino AJ, Farrior E, Burnstine MA Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered intstrumentation endoscopic DCR’s, American Academy of Ophthalmology (AAO), Dallas, Texas, October 24, 2000.
4Burnstine MA Periocular reconstruction. American Academy of Ophthalmology (AAO), New Orleans, Louisiana, November 13, 2001.
5Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Duffy MT,Cohen AJ, Belrado JP, Burnstine MA Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology, (AAO), New Orleans, Louisiana, November 13, 2001.
6Burnstine MA Ask the experts. American Society of Ophthalmic Plastic and Reconstructive Surgery, American Academy of Ophthalmology (AAO), New Orleans, Louisiana, November 12, 2001.
7Esmaeli B, Yeatts RP, Burnstine MA Mazzoli RA, Schaefer DP. Diagnosis and management of periocular and conjunctival malignancies. American Academy of Ophthalmology (AAO), October 20, 2002.
8Mercandetti M, Mirante JP, Silbert D, Weiss RA, Belarado JP, Javate RM, Burnstine MA Duffy MT, Brown MS, Klett ZG, Munier M, Cohen AJ. Dacryoplasty, Balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology, (AAO), New Orleans, Louisiana, October 21, 2002.
9Esmaeli, B, Yeats RP, Burnstine MA Mazzoli RA, Schaeffer DP. Diagnosis and management of periocular and conjunctival malignancies. American Academy of Ophthalmology (AAO), Anaheim, California, November 2003.
10Esmaeli, B, Yeats RP, Burnstine MA Mazzoli RA, Schaeffer DP. Diagnosis and management of periocular and conjunctival malignancies. American Academy of Ophthalmology (AAO), New Orleans, Louisiana, October 26, 2004.
Visiting Professorships
1Burnstine MA Visiting Professor, Servicio Oftalmologio, Universidad de Costa Rica. Lectures on entropion, ectropion, the aging face, transconjunctival blepharoplasty, and ptosis. San José, Costa Rica, January 14, 2000.
2Burnstine MA Visiting Professor, Department of Ophthalmology, University of California San Diego. Lectures on Orbital Imaging and the Aging Face, October 15, 2001.
3Burnstine MA Visiting Professor, Riga, Latvia. Combined ptosis and blepharoplasty, Management of Entropion and Ectropion, Eyelid Lesions, Ptosis Classificationm October, 2008.

Please Call Us Today to Schedule a Consultation

213.986.8789